These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22177002)

  • 1. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention.
    Chan W; Ajani AE; Clark DJ; Stub D; Andrianopoulos N; Brennan AL; New G; Sebastian M; Johnston R; Walton A; Reid CM; Dart AM; Duffy SJ;
    Am J Cardiol; 2012 Feb; 109(4):471-7. PubMed ID: 22177002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
    Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
    Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention.
    Chan W; Stub D; Clark DJ; Ajani AE; Andrianopoulos N; Brennan AL; New G; Black A; Shaw JA; Reid CM; Dart AM; Duffy SJ;
    Am J Cardiol; 2012 Feb; 109(4):478-85. PubMed ID: 22176999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).
    Gilard M; Blanchard D; Helft G; Carrier D; Eltchaninoff H; Belle L; Finet G; Le Breton H; Boschat J;
    Am J Cardiol; 2009 Aug; 104(3):338-42. PubMed ID: 19616664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation.
    Al Khdair D; Alshengeiti L; Elbarouni B; Yan RT; Grondin FR; Spencer FA; Pallie S; Brieger D; Eagle KA; Mangat I; Singh S; Goodman SG; Yan AT;
    Can J Cardiol; 2012; 28(4):443-9. PubMed ID: 22439969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
    Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?
    Lahtela H; Karjalainen PP; Niemelä M; Vikman S; Kervinen K; Ylitalo A; Puurunen M; Porela P; Nyman K; Hinkka-Yli-Salomäki S; Airaksinen KE
    Thromb Haemost; 2009 Dec; 102(6):1227-33. PubMed ID: 19967155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
    Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term mortality associated with ventricular arrhythmia in patients hospitalized with acute coronary syndrome: findings from the Gulf RACE registry-2.
    Hersi A; Alhabib KF; Alsheikh-Ali AA; Sulaiman K; Alfaleh HF; Alsaif S; Al-Mahmeed W; Asaad N; Amin H; Al-Motarreb A; Al Suwaidi J
    Coron Artery Dis; 2013 Mar; 24(2):160-4. PubMed ID: 23363987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Goto K; Nakai K; Shizuta S; Morimoto T; Shiomi H; Natsuaki M; Yahata M; Ota C; Ono K; Makiyama T; Nakagawa Y; Furukawa Y; Kadota K; Takatsu Y; Tamura T; Takizawa A; Inada T; Doi O; Nohara R; Matsuda M; Takeda T; Kato M; Shirotani M; Eizawa H; Ishii K; Lee JD; Takahashi M; Horie M; Takahashi M; Miki S; Aoyama T; Suwa S; Hamasaki S; Ogawa H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2014 Jul; 114(1):70-8. PubMed ID: 24925801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.